Ex-PM Boris Johnson deliberately misled UK parliament over parties during Covid, committee rules

Ex-PM Boris Johnson deliberately misled UK parliament over parties during Covid, committee rules


A U.K. parliamentary committee has found that former U.K. prime minister Boris Johnson intentionally misled parliament over illegal Covid-19 lockdown parties held during his tenure.

Carl Court | Getty Images News | Getty Images

Former U.K. prime minister Boris Johnson intentionally misled parliament over illegal Covid-19 lockdown parties held during his tenure, a parliamentary committee said Thursday, dubbing the act as a “serious contempt.”

The damning verdict of the privilege committee’s long-awaited “partygate” report found that Johnson had willfully deceived parliament several times when probed about Downing Street parties that occurred under his watch and broke his own lockdown rules.

“We conclude that in deliberately misleading the House, Mr Johnson committed a serious contempt,” the findings of the cross-party committee showed.

“There is no precedent for a Prime Minister having been found to have deliberately misled the House,” it added.

The 100-page report, which investigated six gatherings held at the prime minister’s official residence at the time of the U.K.’s most stringent Covid restrictions, also concluded that Johnson was complicit in a “campaign of abuse and attempted intimidation” to disguise the circumstances of those events.

The committee, which consists of members of both the ruling Conservative Party and opposition Labour Party, recommended that Johnson should not be entitled to a former Member’s pass, which allows former prime ministers to access parliament.

It also said that, if Johnson were still a member of parliament, he should be suspended from the House for 90 days. Johnson resigned as a Conservative MP last week after seeing an advanced copy of the report. At the time, he accused the cross-party committee of behaving like a “kangaroo court” conducting a “political hit job” against him.

In a further statement Thursday, he dubbed the findings “rubbish,” “absurd” and “deranged,” according to Perspective magazine and the Telegraph. The ex-prime minister, a fervent Brexiteer, also accused the committee of “prejudicial views,” saying that a majority of members “voted remain” in the 2016 Brexit vote.

“The committee now says that I deliberately misled the House, and at the moment I spoke I was consciously concealing from the House my knowledge of illicit events,” he wrote.

“This is rubbish. It is a lie. In order to reach this deranged conclusion, the committee is obliged to say a series of things that are patently absurd, or contradicted by the fact.”

MPs responsible for producing the report described Johnson’s comments as a blow against U.K. democratic institutions.

“This attack on a committee carrying out its remit from the democratically elected House itself amounts to an attack on our democratic institutions,” the committee said.



Source

Making U.S. biotech more competitive with China’s could help rare disease patients, experts say
Health

Making U.S. biotech more competitive with China’s could help rare disease patients, experts say

The growth of China’s biotechnology sector has been staggering. Beijing is pumping money into the industry, backing research efforts and helping launch a new wave of labs and incubators in the country. That’s a problem for the U.S. biotech industry and also affects rare disease patients who are waiting for a cure. Among the experts […]

Read More
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference
Health

Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good morning from San Francisco! It’s day three of the annual JPMorgan Healthcare Conference – the biggest gathering of biotech and pharma execs, investors and analysts in […]

Read More
OpenAI acquires health-care technology startup Torch
Health

OpenAI acquires health-care technology startup Torch

OpenAI has acquired the health-care technology startup Torch, the company announced on Monday. Torch was building a “unified medical memory” for artificial intelligence that aimed to bring a patient’s health data, which is typically siloed and stored across a number of different vendors and formats, into one place. Torch’s employees will join OpenAI as part […]

Read More